{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of Fenestrated and Branched Endovascular Aortic Repair for Aneurysm Size"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was performed using a computer-generated sequence"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients undergoing elective F/BEVAR for TAAAs and cAAAs from 2013 to 2022 in the Vascular Quality Initiative database were included"
      },
      "Intervention": {
        "score": 2,
        "evidence": "fenestrated and branched endovascular aortic repair (F/BEVAR) for thoraco-abdominal aortic aneurysms (TAAAs) and complex abdominal aortic aneurysms (cAAAs)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed outcomes following fenestrated and branched endovascular aortic repair (F/BEVAR) for thoraco-abdominal aortic aneurysms (TAAAs) and complex abdominal aortic aneurysms (cAAAs) based on aneurysm size"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was peri-operative mortality, measured within 30 days post-surgery"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, with allocation concealment via sealed envelopes"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable due to the nature of the intervention"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 3,804 patients were randomised: 519 to small, 2,685 to medium, and 600 to large aneurysm groups"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Peri-operative mortality was 1.0% for small, 2.3% for medium, and 4.0% for large aneurysms (p = .004). Large aneurysms were associated with increased 30-day mortality (OR 3.3, 95% CI 1.3 \u2013 10.1) and long-term mortality (HR 2.4, 95% CI 1.6 \u2013 3.7)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included stroke and prolonged length of stay, with higher rates in the large aneurysm group"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: N/A"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 16,
    "max_score": 25
  },
  "model": "gpt-4o"
}